Effect of Training With Wireless Lightning Reaction Systems on Cognitive Functions in Individuals With Multiple Sclerosis
Launched by EGE UNIVERSITY · Mar 7, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special training program using technology can help improve thinking skills, balance, and walking in people with Multiple Sclerosis (MS). The researchers want to see if using a reaction system—an interactive device designed to enhance agility and reaction time—can lead to better cognitive function and overall quality of life for those living with MS. Participants will engage in exercises that challenge their balance and coordination, with the hope that this training will reduce disability and make daily activities easier.
To be eligible for this trial, participants should be between 18 and 55 years old, have a confirmed diagnosis of MS, and have a certain level of disability as measured by a specific scale. It’s important that they can communicate effectively in Turkish and have not exercised regularly in the past six months. Participants should also be in stable health without recent MS attacks or other serious health issues. This trial is not yet recruiting, but it hopes to provide valuable insights into improving the lives of those with MS through innovative training methods.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being between the ages of 18-55
- • Having a definite MS diagnosis according to the 2017 McDonald criteria.
- • EDSS score of 4 or below
- • Being able to communicate (speaking and understanding Turkish, no speech disorders)
- Exclusion Criteria:
- • Regular exercise in the last 6 months
- • Having an MS attack in the last month
- • Having an MS attack during the study period
- • Presence of additional accompanying neurological diseases
- • Use of dalfampridine
- • Use of antipsychotic and psychostimulant drugs
- • Drug and alcohol addiction
- • Pregnancy, breastfeeding
- • No chronic systemic disease preventing exercise
- • Patients who cannot reach the targeted exercise level
About Ege University
Ege University, a prestigious institution located in Izmir, Turkey, is renowned for its commitment to advancing medical research and education. As a prominent clinical trial sponsor, Ege University leverages its extensive academic resources and expertise in various healthcare fields to facilitate innovative clinical studies. The university is dedicated to enhancing patient care through rigorous research methodologies and collaboration with multidisciplinary teams, ensuring the development of effective therapies and interventions. With a strong focus on ethical standards and regulatory compliance, Ege University aims to contribute significantly to the global medical community by fostering groundbreaking discoveries and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İzmir, Bornova, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported